|
業務類別
|
-- |
|
業務概覽
|
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders, but in February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for only 8% of 2021 revenue. Ipsen has alarge global footprint and sells more than 20 drugs in 115 countries. |
| 公司地址
| 70 rue Balard, Paris, FRA, 75015 |
| 電話號碼
| +33 158335000 |
| 傳真號碼
| +33 158335001 |
| 公司網頁
| https://www.ipsen.com |
| 員工數量
| 5535 |
| Mr. David Loew |
Director and Chief Executive Officer |
-- |
08/04/2025 |
|
|
| Dr. Pascal Touchon, D.V.M. |
Independent Director |
08/04/2025 |
| Dr. Margaret A. Liu, M.D. |
Independent Director |
08/04/2025 |
| Ms. Karen Witts |
Independent Director |
08/04/2025 |
| Ms. Carol Xueref |
Director |
08/04/2025 |
| Dr. Piet Wigerinck, PhD |
Independent Director |
08/04/2025 |
| Mr. David Loew |
Director and Chief Executive Officer |
08/04/2025 |
| Mr. Marc de Garidel |
Chairman of the Board |
08/04/2025 |
| Ms. Anne Beaufour |
Director |
08/04/2025 |
| Mr. Antoine Flochel |
Vice Chairman of the Board |
08/04/2025 |
| Mr. Henri Beaufour |
Director |
08/04/2025 |
| Mr. Philippe Bonhomme |
Director |
08/04/2025 |
| Ms. Laetitia Ducroquet |
Director |
08/04/2025 |
| Ms. Naomi Binoche |
Director |
08/04/2025 |
| Ms. Michele Ollier |
Director |
08/04/2025 |
|
|
|
|
